9th IAS Conference on HIV Science (IAS 2017)

1 October 2017. Related: Conference reports, Conference index, IAS 9th Paris 2017.

The 9th IAS Conference on HIV Science (IAS 2017) was held from 23–26 July 2017.

As with all IAS conferences, many of the key presentations are available online after the meeting.

All abstracts are also posted online, with full versions of the posters and presentations often also available from the conference website.
http://www.ias2017.org

Webcasts are published to three different webpages:

The main IAS 2017 youtube channel includes most oral abstract presentations and some plenary sessions.
IAS 2017 on youtube.com

Live broadcasts for opening and closing ceremonies, and some press conferences are at this link on the conference website. Currently the link to the closing ceremonies with rapporteur summaries and the community speech is not available.
http://www.ias2017.org/Get-Involved/IAS-2017-Live

Press conferences and other webcasts are online on a different IAS youtube channel.
IAS 2017 press conference webcasts

Articles in this issue are:

• Dual therapy with darunavir/r plus lamivudine as first-line ART

• Dual therapy with dolutegravir plus lamivudine as first-line ART

• Once-daily raltegravir: 96-week results from the ONCEMRK study

• New IPERGAY analysis shows on-demand PrEP dosing works with less frequent sex

• On-demand dosing for PrEP is highly effective in French expanded access programme

• Psychological impact of PrEP: beyond efficacy and cost-effectiveness

• Early ART and testing HIV negative with rapid HIV tests

• Report from the IAS HIV Cure & Cancer Forum, 22–23 July 2017, Paris